United States Prostate Cancer Drugs Market Research Report Forecast 2017-2021

May 2017 | 126 pages | ID: UF765A18FAAEN
S&P Consulting

Abstracts

The United States Prostate Cancer Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Prostate Cancer Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Prostate Cancer Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer

United States Prostate Cancer Drugs Market: Product Segment Analysis
Type 1
Type 2
Type 3

United States Prostate Cancer Drugs Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 PROSTATE CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Prostate Cancer Drugs Market Segmentation by Type
  1.2.1 United States Production Market Share of Prostate Cancer Drugs by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Prostate Cancer Drugs Market Segmentation by Application
  1.3.1 Prostate Cancer Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Prostate Cancer Drugs (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON PROSTATE CANCER DRUGS INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES PROSTATE CANCER DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 United States Prostate Cancer Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 United States Prostate Cancer Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Prostate Cancer Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Prostate Cancer Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Prostate Cancer Drugs Market Competitive Situation and Trends
  3.5.1 Prostate Cancer Drugs Market Concentration Rate
  3.5.2 Prostate Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES PROSTATE CANCER DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Prostate Cancer Drugs Production and Market Share by Type (2012-2017)
4.2 United States Prostate Cancer Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Prostate Cancer Drugs Price by Type (2012-2017)
4.4 United States Prostate Cancer Drugs Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES PROSTATE CANCER DRUGS MARKET ANALYSIS BY APPLICATION

5.1 United States Prostate Cancer Drugs Consumption and Market Share by Application (2012-2017)
5.2 United States Prostate Cancer Drugs Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES PROSTATE CANCER DRUGS MANUFACTURERS ANALYSIS

6.1 Bristol-Myers Squibb
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 AstraZeneca
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Eli Lilly
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Roche
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 GSK
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Novartis
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Pfizer
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Sanofi
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Bayer
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 PROSTATE CANCER DRUGS MANUFACTURING COST ANALYSIS

7.1 Prostate Cancer Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prostate Cancer Drugs

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prostate Cancer Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES PROSTATE CANCER DRUGS MARKET FORECAST (2017-2021)

11.1 United States Prostate Cancer Drugs Production, Revenue Forecast (2017-2021)
11.2 United States Prostate Cancer Drugs Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Prostate Cancer Drugs Production Forecast by Type (2017-2021)
11.4 United States Prostate Cancer Drugs Consumption Forecast by Application (2017-2021)
11.5 Prostate Cancer Drugs Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostate Cancer Drugs
Table Classification of Prostate Cancer Drugs
Figure United States Sales Market Share of Prostate Cancer Drugs by Type in 2015
Table Application of Prostate Cancer Drugs
Figure United States Sales Market Share of Prostate Cancer Drugs by Application in 2015
Figure United States Prostate Cancer Drugs Sales and Growth Rate (2011-2021)
Figure United States Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
Table United States Prostate Cancer Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Prostate Cancer Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prostate Cancer Drugs Sales Share by Manufacturers
Figure 2016 Prostate Cancer Drugs Sales Share by Manufacturers
Table United States Prostate Cancer Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Prostate Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Prostate Cancer Drugs Revenue Share by Manufacturers
Table 2016 United States Prostate Cancer Drugs Revenue Share by Manufacturers
Table United States Market Prostate Cancer Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Prostate Cancer Drugs Average Price of Key Manufacturers in 2015
Figure Prostate Cancer Drugs Market Share of Top 3 Manufacturers
Figure Prostate Cancer Drugs Market Share of Top 5 Manufacturers
Table United States Prostate Cancer Drugs Sales by Type (2012-2017)
Table United States Prostate Cancer Drugs Sales Share by Type (2012-2017)
Figure United States Prostate Cancer Drugs Sales Market Share by Type in 2015
Table United States Prostate Cancer Drugs Revenue and Market Share by Type (2012-2017)
Table United States Prostate Cancer Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prostate Cancer Drugs by Type (2012-2017)
Table United States Prostate Cancer Drugs Price by Type (2012-2017)
Figure United States Prostate Cancer Drugs Sales Growth Rate by Type (2012-2017)
Table United States Prostate Cancer Drugs Sales by Application (2012-2017)
Table United States Prostate Cancer Drugs Sales Market Share by Application (2012-2017)
Figure United States Prostate Cancer Drugs Sales Market Share by Application in 2015
Table United States Prostate Cancer Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Prostate Cancer Drugs Sales Growth Rate by Application (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Prostate Cancer Drugs Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Prostate Cancer Drugs Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Prostate Cancer Drugs Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Roche Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Roche Prostate Cancer Drugs Market Share (2012-2017)
Table GSK Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GSK Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table GSK Prostate Cancer Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Prostate Cancer Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Prostate Cancer Drugs Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Prostate Cancer Drugs Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Prostate Cancer Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Prostate Cancer Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure United States Prostate Cancer Drugs Production and Growth Rate Forecast (2017-2021)
Figure United States Prostate Cancer Drugs Revenue and Growth Rate Forecast (2017-2021)
Table United States Prostate Cancer Drugs Production Forecast by Type (2017-2021)
Table United States Prostate Cancer Drugs Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer
Celgene